<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>RSS for Nnaemeka Amobi</title><link>http://academic.research.microsoft.com/Rss.aspx?id=54105697</link><description>Search RSS feed for Microsoft Academic Search</description><generator>MSRA Libra RSS Burner</generator><copyright>(c)2008 Microsoft Corpration, All right reserved.</copyright><pubDate>Thu, 20 Jun 2013 08:33:41 GMT</pubDate><lastBuildDate>Thu, 20 Jun 2013 08:33:41 GMT</lastBuildDate><category /><item><title>Nnaemeka Amobi (Personal Info)
      </title><link>http://academic.research.microsoft.com/Author/54105697</link><pubDate>Thu, 20 Jun 2013 08:33:41 GMT</pubDate><description><![CDATA[<p>King's College London<br/></p><p>
          Publications: 7</p><p>
          Citation Count: 27</p><p>
          G-index: 5</p><p>
         Field Rating: 3</p><p>Fields of study: <a href="http://academic.research.microsoft.com/RankList?entitytype=2&topDomainID=6&subDomainID=20&last=0&start=1&end=100">Pharmacology</a><span class="span-break" >,&nbsp;</span><a href="http://academic.research.microsoft.com/RankList?entitytype=2&topDomainID=6&subDomainID=23&last=0&start=1&end=100">Urology</a><br/></p><p>Homepage:
        <a href="" /></p><p>
          Permanent Link:
          <a href="http://academic.research.microsoft.com/Author/54105697">http://academic.research.microsoft.com/Author/54105697</a></p>]]></description><guid isPermaLink="false">5410573135King's College London</guid></item><item><title>Contractile actions of L-type Ca 2 + agonists in human vas deferens and effects of structurally different Ca 2 + antagonists</title><link>http://academic.research.microsoft.com/Publication/34905813</link><pubDate>Thu, 20 Jun 2013 08:33:41 GMT</pubDate><guid isPermaLink="false">5410569734905813</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I. Christopher H. Smith</a></dl><p></p><p>EUR J PHARMACOL, vol. 627, no. 1, pp. 285-294, 2010</p><p>(Citations:1)</p>]]></description></item><item><title>Comparative effects of T-type and L-type Ca2+-antagonists against noradrenaline-induced contractions of human vas deferens: T-TYPE AND L-TYPE CA2+-ANTAGONISTS AGAINST NORADRENALINE-INDUCED CONTRACTIONS OF VAS DEFERENS</title><link>http://academic.research.microsoft.com/Publication/31424557</link><pubDate>Thu, 20 Jun 2013 08:33:40 GMT</pubDate><guid isPermaLink="false">5410569731424557</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/47260019'>Christopher H. Smith</a></dl><p></p><p>BJU INT, vol. 106, no. 4, pp. 578-585, 2009</p><p />]]></description></item><item><title>Contractile actions of imidazoline α-adrenoceptor agonists and effects of noncompetitive α 1-adrenoceptor antagonists in human vas deferens</title><link>http://academic.research.microsoft.com/Publication/34900639</link><pubDate>Thu, 20 Jun 2013 08:33:39 GMT</pubDate><guid isPermaLink="false">5410569734900639</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/56345989'>Amir Kaisary</a>,  <a href='http://academic.research.microsoft.com/Author/55182821'>R. W Lloyd-Davies</a>,  <a href='http://academic.research.microsoft.com/Author/42039436'>Eileen Turner</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I. Christopher H Smith</a></dl><p></p><p>EUR J PHARMACOL, vol. 462, no. 1, pp. 169-177, 2003</p><p>(Citations:3)</p>]]></description></item><item><title>Corrigendum to “Contractile actions of imidazoline α-adrenoceptor agonists and effects of noncompetitive α 1-adrenoceptor antagonists in human vas deferens”</title><link>http://academic.research.microsoft.com/Publication/34900693</link><pubDate>Thu, 20 Jun 2013 08:33:38 GMT</pubDate><guid isPermaLink="false">5410569734900693</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/56345989'>Amir Kaisary</a>,  <a href='http://academic.research.microsoft.com/Author/55182821'>R. W Lloyd-Davies</a>,  <a href='http://academic.research.microsoft.com/Author/42039436'>Eileen Turner</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I. Christopher H Smith</a></dl><p></p><p>EUR J PHARMACOL, vol. 464, no. 2, pp. 241-241, 2003</p><p />]]></description></item><item><title>Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens</title><link>http://academic.research.microsoft.com/Publication/38256481</link><pubDate>Thu, 20 Jun 2013 08:33:37 GMT</pubDate><guid isPermaLink="false">5410569738256481</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka I. B. Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/56345989'>A V. Kaisary</a>,  <a href='http://academic.research.microsoft.com/Author/42039436'>Eileen Turner</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I Christopher H. Smith</a></dl><p></p><p>BRIT J PHARMACOL, vol. 136, no. 1, pp. 127-135, 2002</p><p>(Citations:9)</p>]]></description></item><item><title>Functional characterization of α 1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens</title><link>http://academic.research.microsoft.com/Publication/34897315</link><pubDate>Thu, 20 Jun 2013 08:33:36 GMT</pubDate><guid isPermaLink="false">5410569734897315</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/54937572'>John Guillebaud</a>,  <a href='http://academic.research.microsoft.com/Author/21468917'>Charles Coker</a>,  <a href='http://academic.research.microsoft.com/Author/7631976'>David Mulvin</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I. Christopher H Smith</a></dl><p></p><p>EUR J PHARMACOL, vol. 367, no. 2, pp. 291-298, 1999</p><p>(Citations:9)</p>]]></description></item><item><title>The human vas deferens: correlation of response pattern to noradrenaline and histological structure</title><link>http://academic.research.microsoft.com/Publication/34893481</link><pubDate>Thu, 20 Jun 2013 08:33:35 GMT</pubDate><guid isPermaLink="false">5410569734893481</guid><description><![CDATA[<dl><a href='http://academic.research.microsoft.com/Author/54105697'>Nnaemeka Amobi</a>,  <a href='http://academic.research.microsoft.com/Author/26193558'>I. Christopher H. Smith</a></dl><p></p><p>EUR J PHARMACOL, vol. 273, no. 1, pp. 25-34, 1995</p><p>(Citations:5)</p>]]></description></item></channel></rss>